MEDNAX Inc
NYSE:MD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SSAB AB
STO:SSAB A
|
SE |
|
Zanyu Technology Group Co Ltd
SZSE:002637
|
CN |
|
Neuland Laboratories Ltd
NSE:NEULANDLAB
|
IN |
MEDNAX Inc
EPS (Diluted)
MEDNAX Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
MEDNAX Inc
NYSE:MD
|
EPS (Diluted)
$1
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-6%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
EPS (Diluted)
$8
|
CAGR 3-Years
3%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
6%
|
|
|
CVS Health Corp
NYSE:CVS
|
EPS (Diluted)
$1
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-11%
|
|
|
Cigna Corp
NYSE:CI
|
EPS (Diluted)
$22
|
CAGR 3-Years
1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
11%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
EPS (Diluted)
$10
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
9%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
EPS (Diluted)
-$3
|
CAGR 3-Years
20%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
MEDNAX Inc
Glance View
MEDNAX Inc., a healthcare company often flying under the radar of typical mainstream attention, operates at the heart of the medical services industry by providing specialized services in neonatology, anesthesia, pediatrics, and radiology. Emerging from its inception in 1979, MEDNAX has carved out a unique footprint by associating with a network of physicians and advanced practitioners who deliver targeted services. The company orchestrates a seamless operation where these medical professionals are not merely standalone entities but integral components of a broader service platform. They engage in practices that fill a critical gap in the healthcare ecosystem: providing expertise-driven, high-touch care primarily in hospital settings, where the demand for precise and nuanced medical attention is the highest. Financially, MEDNAX derives revenue from agreements forged with hospitals and health systems, wherein these institutions pay for the specialized care delivery services. The company also taps into the insurance revenue stream, billing patients’ insurance providers for the medical services rendered. With a business model deeply embedded in partnerships, MEDNAX leverages its expansive nationwide network of clinicians to negotiate advantageous service agreements and efficiently manage the reimbursement landscape. By aligning its operational focus with key medical sectors that are consistently in need of expert intervention and by building a flexible, scalable service model, MEDNAX ensures its revenue streams remain robust while it continues to adapt to the vicissitudes of the healthcare industry.
See Also
What is MEDNAX Inc's EPS (Diluted)?
EPS (Diluted)
1.9
USD
Based on the financial report for Dec 31, 2025, MEDNAX Inc's EPS (Diluted) amounts to 1.9 USD.
What is MEDNAX Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-6%
The average annual EPS (Diluted) growth rates for MEDNAX Inc have been 35% over the past three years , and -6% over the past ten years .